Haas Kevin Richard bought MYGN
March 13, 2025 · Form 4 insider transaction
Haas Kevin Richard bought 54,124 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
54,124
Price
$0.00
Total value
N/A
InsiderHaas Kevin Richard
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 13, 2025
Filing dateMarch 17, 2025
Shares owned after195,448
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.